Lawmakers Demand Investigation Of A Research Program Involving Chantix
Date: 17th June 2008
According to a latest revelation by the Washington Times and ABC News, the Department of Veteran Affairs is initiating a research program that involves the administration of Chantix, the quit smoking medicine to veterans suffering from post-traumatic stress disorder who are eager to trigger off smoking cessation. Furthermore, it is known that lawmakers are seeking out an investigation into this research program that also encourages the payment of stipend to participants as the anti-smoking drug chantix used in the research is found to yield significantly dangerous side-effects.
According to sources, the FDA has issued warnings against chantix after several chantix users have reportedly fallen prey to psychotic behavior such as hallucinations and suicide attempts. In connection with the warnings issued by FDA, officials of the Department of Veteran Affairs make it apparent that they have communicated the warnings to the doctors.
Responding to news that appeared in Washington Times and ABC News, the Veteran officials have clarified that the reports are misleading and altogether incorrect and with regard to the payment of stipends, the officials reveal that the distribution of stipends among people enrolled for any experiment is a general practice in the medical world. In support of the initiative taken by the Department of Veteran Affairs, the officials of the department state that every individual enrolled for the research has been closely supervised and the medicine chantix(Varenicline) used in the experiment has been duly approved by the Food and Drugs Administration(FDA).
However, the article published in Washington Times clarify that the fee paid to veterans participating in the study amounts to $30 on a monthly basis.